Itacitinib for the Prevention of Graft Versus Host Disease in Patients Undergoing Donor Stem Cell Transplantation

Clinical trial NCT04127721 · WITHDRAWN

Trial details

NCT number: NCT04127721
Sponsor: M.D. Anderson Cancer Center
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Allogeneic Stem Cell Transplant Recipient Hematologic and Lymphocytic Disorder Hematopoietic and Lymphoid Cell Neoplasm

Start date: 2020-09-22
Primary completion: 2020-09-22
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.